# clm_74B5C29B477B

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: quarterly_net_income  
value: 5,582,500,000 United States dollar  
valid_from: 2025-09-30  
valid_to: 2026-03-31  
published: 2025-10-30  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_063460475B4C  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company quarterly net income: 5,582,500,000 United States dollar", as of 2025-09-30 (until 2026-03-31). Claim clm_74B5C29B477B, https://asof.is/claim/clm_74B5C29B477B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-30  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947825000254/0000059478-25-000254-index.htm (primary, SEC EDGAR 10-Q Q3 FY2025, published 2025-10-30)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | quarterly_net_income | 5,660,500,000 United States dollar | valid 2025-06-30 to 2025-09-30 | conf 0.95 | superseded | superseded_by [clm_74B5C29B477B](/claim/clm_74B5C29B477B.md) | [clm_1D33827F581C](/claim/clm_1D33827F581C.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.